Skip to content

Advertisement

  • Poster presentation
  • Open Access

Dosage and side effects of clozapine

  • 1,
  • 2 and
  • 1
Annals of General Psychiatry20065 (Suppl 1) :S80

https://doi.org/10.1186/1744-859X-5-S1-S80

  • Published:

Keywords

  • Weight Gain
  • Clozapine
  • Cardiac Event
  • Patient Compliance
  • Agranulocytosis

Background

Clozapine has decreased side effects burden compared with conventional antipsychotics which leads to better patient compliance and results in greater effectiveness. The discovering of clozapine has shown that neurological side effects are not obligatory when treating psychosis but there's risk of agranulocytosis and some other side effects (hypersalivation, sedation, weight gain etc.) The mean dose of clozapine differs between Europe and the United States and the side effects are often the limiting factor for doctors when dosing clozapine.

Materials and methods

The sample included 104 in and out patients treated with clozapine. Side-effects (number of leukocytes, sedation, hypersalivation, dry mouth, extrapyramidal symptomatology, blood pressure fall, maculopapular rush, vomiting and weight gain) were identified with the use of clinical examinations and laboratory analyses. The patients' diagnoses were F20 (66%), F22 and F23 (12%), F25 (16%), F31 and F32 (2%), and other (4%). Our investigation has been carried out in three periods: 7 days after the beginning of therapy, after two and after six months since the beginning.

Results

The number of different side effects decreases during the time, also as the frequency of registered side effects. The patients did not report any severe or unexpected side-effects. The mean dose of clozapine is not significantly higher during those six months. The side effects are not limiting factor when dosing clozapine.

Discussion

Clozapine was effective and safe drug for acute and long-term treatment. Patients didn't report any severe or unexpected side effects. According to the published literature, there are side-effects that we should examine also (cardiac events, diabetes, and hyperlipidemia). In view of the results, it is recommended that the treatment with clozapine should be continually evaluated in the future, in order to detect and prevent all side-effects connected with the use of a widespread antipsychotic such as clozapine.

Authors’ Affiliations

(1)
Institute of Mental Health, Serbia and Montenegro
(2)
Institute of Neuropsychiatry "Dr. Laza Lazarevic", Serbia and Montenegro

References

  1. Ananth J, Venkatesh R, Burgoyne K, Gadasalli R, Binford R, Gunatilake S: Atypical antipsychotic induced weight gain: pathophysiology and management. Ann Clin Psychiatry. 2004, 16: 75-85.View ArticlePubMedGoogle Scholar
  2. Kaplan and Sadock's: Comprehensive Textbook of Psychiatry. Seventh edition.Google Scholar
  3. Merrill DB, Dec GW, Goff DC: Adverse cardiac effects associated with clozapine. J Clin Psychopharmacol. 2005, 25: 32-41. 10.1097/01.jcp.0000150217.51433.9f.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2006

Advertisement